Biophytis News

BPTSDelisted Stock  USD 7.03  0.00  0.00%   
Slightly above 56% of Biophytis' investor base is looking to short. The analysis of current outlook of investing in Biophytis suggests that many traders are alarmed regarding Biophytis' prospects. Biophytis' investing sentiment can be driven by a variety of factors including economic data, Biophytis' earnings reports, geopolitical events, and overall market trends.
  
over six months ago at finance.yahoo.com         
Why Is Penny Stock Biophytis Trading Higher On Tuesday?
Yahoo News
over six months ago at accesswire.com         
Biophytis launches OBA phase 2 clinical study in obesity with BIO101
news
over six months ago at finance.yahoo.com         
Biophytis launches OBA phase 2 clinical study in obesity with BIO101
Yahoo News
over six months ago at finance.yahoo.com         
Biophytis Announces Its 2023 Financial Results and Provides an Update on Its Business Activities
Yahoo News
over six months ago at finance.yahoo.com         
Results of the Combined General Meeting on April 2, 2024
Yahoo News
over six months ago at news.google.com         
12 Health Care Stocks Moving In Fridays After-Market Session - Biophytis , Applied Therapeutics ... ...
Google News at Macroaxis
over six months ago at news.google.com         
Why Salarius Pharmaceuticals Shares Are Trading Higher By Around 31 Here Are 20 Stocks Moving Premar...
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Biophytis Presented its Phase 3 Protocol in the Treatment of Sarcopenia
Yahoo News
over six months ago at news.google.com         
Todays Biggest Pre-Market Stock Movers 10 Top Gainers and Losers on Thursday - InvestorPlace
Google News at Macroaxis
over six months ago at thelincolnianonline.com         
Biophytis S.A. Short Interest Update
news
over six months ago at thelincolnianonline.com         
Biophytis S.A. Sees Large Increase in Short Interest
news
over a year ago at news.google.com         
Biophytis two appointments to scientific committee -November 27 ... - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Biophytis Announces Receipt of Nasdaq Notice - Yahoo Finance
Google News at Macroaxis
over a year ago at seekingalpha.com         
Biophytis SA receives non compliance notice from Nasdaq
seekingalpha News
over a year ago at finance.yahoo.com         
Biophytis Announces Receipt of Nasdaq Notice
Yahoo News
Far too much social signal, news, headlines, and media speculation about Biophytis that are available to investors today. That information is available publicly through Biophytis media outlets and privately through word of mouth or via Biophytis internal channels. However, regardless of the origin, that massive amount of Biophytis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Biophytis news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Biophytis relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Biophytis' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Biophytis alpha.

Biophytis Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Biophytis launches OBA phase 2 clinical study in obesity with BIO101
04/08/2024
2
Why Is Biophytis Stock Up 43 percent Today
04/09/2024
3
Biotech Catches Major Premarket Bid Following Financial Results - MSN
04/15/2024
4
Biophytis unveils design for obesity study - Marketscreener.com
05/14/2024
5
Biophytis Advances DMD Treatment with BIO101 Scale-Up - TipRanks.com - TipRanks
06/14/2024
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Consideration for investing in Biophytis Stock

If you are still planning to invest in Biophytis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biophytis' history and understand the potential risks before investing.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios